High Density Insulin Receptor-Positive T Lymphocytes from Nonobese Diabetic Mice Transfer Insulitis and Diabetes

Journal of Immunology

Volumn 157, Issue 8, 1996, Pages 3716-3726

  McInerney, Marcia F ^a   Flynn, Jeffrey C ^a   Goldblatt, Peter J ^a   Najjar, Sonia M ^a   Sherwin, Robert S ^b   Janeway Jr , Charles A ^b  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; INSULIN RECEPTOR;

ANIMAL; ARTICLE; FEMALE; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLISM; MOUSE; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PASSIVE IMMUNIZATION; PATHOLOGY; SPLEEN; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIBODIES; DIABETES MELLITUS, TYPE 1; FEMALE; IMMUNIZATION, PASSIVE; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED NOD; RECEPTOR, INSULIN; SPLEEN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 0030587853     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Makino, S., K. Kunimoto, Y. Muraoka, Y. Mizushima, K. Katagiri, and Y. Tochino. 1980. Breeding of a non-obese, diabetic strain of mice. Exp. Anim. 29:1.
2. Wang, Y., L. Hao, R. G. Gill, and K. J. Lafferty. 1987. Autoimmune diabetes in NOD mouse is L3T4 T-lymphocyte dependent. Diabetes 36:535.
3. Like, A. A., C. A. Biron, E. J. Weringer, K. Byman, E. Sroczynski, and D. L. Guberski. 1986. Prevention of diabetes in Biobreeding/Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells. J. Exp. Med. 164:1145.
4. Sibley, R. K., and D. E. R. Sutherland. 1987. Pancreas transplantation - an immunohistologic and histopathologic examination of 100 grafts. Am. J. Pathol. 128:151.
5. + T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J. Immunol. 140:52.
6. + T cells. J. Exp. Med. 166:823.
7. Fujita, T., R. Yui, Y. Kusumoto, Y. Serizawa, S. Makino, and Y. Tochino. 1982. Lymphocytic insulitis in a 'non-obese diabetic (NOD)' strain of mice: an immunohistochemical and electron microscope investigation. Biomed. Res. 3:429.
8. Haskins, K., M. Portas, B. Bradley, D. Wegmann, and K. Lafferty. 1988. T-Lymphocyte clone specific for pancreatic islet antigen. Diabetes 37:1444.
9. Reich, E., R. S. Sherwin, O. Kanagawa, and C. A. Janeway, Jr. 1989. An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes. Nature 341:326.
10. Eisenbarth, G. S. 1987. Genes, generator of diversity, glycoconjugates, and autoimmune β-cell insufficiency in Type I diabetes. Diabetes 36:355.
11. Kay, T. W. H., I. L. Campbell, and L. C. Harrison. 1991. Characterization of pancreatic T lymphocytes associated with beta cell destruction in the non-obese diabetic (NOD) mouse. J. Autoimmun. 4:263.
12. Helderman, J. H., T. C. Reynolds, and T. B. Strom. 1978. The insulin receptor as a universal marker of activated lymphocytes. Eur. J. Immunol. 8:589.
13. Goodman, D. W., and P. C. Isakson. 1993. Mitogen activation of resting lymphocytes exposes cryptic insulin receptors. J. Biol. Chem. 268:4207.
14. Fantus, I. G., J. Ryan, N. Hizuka, and P. Gorden. 1981. The effect of glucocorticoids on the insulin receptor: an in vivo and in vitro study. J. Clin. Endocrinol. Metab. 52:953.
15. Helderman, J. H., and T. B. Strom. 1977. Emergence of insulin receptors upon alloimmune T cells in the rat. J. Clin. Invest. 59:338.
16. Braciale, V. L., J. R. Gavin III, and T. J. Braciale. 1982. Inducible expression of insulin receptors on T lymphocyte clones. J. Exp. Med. 156:664.
17. Fantus, I. G., G. A. Saviolakis, J. A. Hedo, and P. Gorden. 1982. Mechanism of glucocorticoid-induced increase in insulin receptors of cultured human lymphocytes. J. Biol. Chem. 257:8277.
18. Yenush, L., V. Kundra, M. F. White, and B. R. Zetter. 1994. Functional domains of the insulin receptor responsible for chemotactic signaling. J. Biol. Chem. 269: 100.
19. Leiter, E. H. 1987. Murine macrophages and pancreatic β cells: chemotactic properties of insulin and β-cytostatic action of interleukin 1. J. Exp. Med. 166: 1174.
20. Berman, J. S., and D. M. Center. 1987. Chemotactic activity of porcine insulin for human T lymphocytes in vitro. J. Immunol. 138:2100.
21. Bacelj, A., B. Charlton, and T. E. Mandel. 1989. Prevention of cyclophosphamide-induced diabetes by anti-Vβ8 T-lymphocyte-receptor monoclonal antibody therapy in NOD/Wehi mice. Diabetes 38:1492.
22. Edouard, P., C. Thivolet, P. Bedossa, M. Olivi, B. Legrand, A. Bendelac, J.-F. Bach, and C. Carnaud. 1993. Evidence for a preferential Vβ usage by the T cells which adoptively transfer diabetes in NOD mice. Eur. J. Immunol. 23:727.
23. Nakano, N., H. Kikutani, H. Nishimoto, and T. Kishimoto. 1991. T cell receptor V gene usage of islet β cell-reactive T cells is not restricted in non-obese diabetic mice. J. Exp. Med. 173:1091.
24. McDuffie, M. 1991. Diabetes in NOD mice does not require T lymphocytes expressing Vβ8 or Vβ5. Diabetes 40:1555.
25. Zhang, B., and R. A. Roth. 1991. A region of the insulin receptor important for ligand binding (residues 450-601) is recognized by patients' autoimmune antibodies and inhibitory monoclonal antibodies. Proc. Natl. Acad. Sci. USA 88: 9858.
26. Prigent, S. A., K. K. Stanley, and K. Siddle. 1990. Identification of epitopes on the human insulin receptor reacting with rabbit polyclonal antisera and mouse monoclonal antibodies. J. Biol. Chem. 265:9970.
27. Ganderton, R. H., K. K. Stanley, C. E. Field, M. P. Coghlan, M. A. Soos, and K. Siddle. 1992. A monoclonal anti-peptide antibody reacting with the insulin receptor β-subunit. Characterization of the antibody and its epitope and use in immunoaffinity purification of intact receptors. Biochem. J. 288:195.
28. Cama, A., B. Marcus-Samuels, and S. J. Taylor. 1988. Immunological abnormalities in insulin receptors on cultured EBV-transformed lymphocytes from insulin-resistant patient with leprechaunism. Diabetes 37:982.
29. Portoles, P., J. Rojo, A. Golby, M. Bonneville, S. Gromkowski, L. Greenbaum, C. A. Janeway, Jr., D. B. Murphy, and K. Bottomly. 1989. Monoclonal antibodies to murine CD3∈ define distinct epitopes, one of which may interact with CD4 during T cell activation. J. Immunol. 142:4169.
30. Wigzell, H. 1976. Enrichment or depletion of surface-immunoglobulin-coated cells using anti-immunoglobulin antibodies and glass or plastic bead columns. In In Vitro Methods in Cell-Mediated and Tumor Immunity. B. R. Bloom, and J. R. David, eds. Academic Press, Inc., New York, p. 245.
31. Whittaker, J., A. K. Okamato, R. Thys, G. I. Bell, D. F. Steiner, and C. A. Hofmann. 1987. High-level expression of human insulin receptor cDNA in mouse NIH 3T3 cells. Proc. Natl. Acad. Sci. USA 84:5237.
32. Najjar, S. M., N. Philippe, Y. Suzuki, G. A. Ignacio, P. Formisano, D. Accili, and S. I. Taylor. 1995. Insulin-stimulated phosphorylation of recombinant pp120/ HA4, an endogenous substrate of the insulin receptor tyrosine kinase. Biochemistry 34:9341.
33. Hedo, J. A., M. Kasuga, E. van Obberghen, J. Roth, and C. R. Kahn. 1981. Direct demonstration of glycosylation of insulin receptor subunits by biosynthetic and external labeling: evidence for heterogeneity. Proc. Natl. Acad. Sci. USA 78: 4791.
34. Hedo, J. A., C. R. Kahn, M. Hayashi, K. M. Yamada, and M. Kasuga. 1983. Biosynthesis and glycosylation of the insulin receptor. Evidence for a single polypeptide precursor of the two major subunits. J. Biol. Chem. 258:10020.
35. Prowse, S. J., C. J. Simeonovic, K. J. Lafferty, B. C. Bond, C. E. Magi, and D. Mackie. 1984. Allogenic islet transplantation without recipient immunosuppression. In Methods in Diabetes Research, Vol. I: Laboratory Methods, Part B. J. Larner and S. L. Pohl, eds. John Wiley & Sons, Inc., New York, p. 253.
36. + cells in pancreatic islets of NOD mice. Diabetes 40:648.
37. Knutson, V. P. 1991. Cellular trafficking and processing of the insulin receptor. FASEB J. 5:2130.
38. Clevers, H., B. Alarcon, T. Wileman, and C. Terhorst. 1988. The T cell receptor/ CD3 complex: a dynamic protein ensemble. Annu. Rev. Immunol. 6:629.
39. Yoon, S. T., U. Dianzani, K. Bottomly, and C. A. Janeway, Jr. 1994. Both high and low avidity antibodies to the T cell receptor can have agonist or antagonist activity. Immunity 1:563.
40. Cantrell, D. A., and K. A. Smith. 1984. The interleukin-2 T-cell system: a new cell growth model. Science 224:1312.
41. Omary, M. B., I. S. Trowbridge, and J. Minowada. 1980. Human cell-surface glycoprotein with unusual properties. Nature 286:888.
42. Mamula, M. J., and C. A. Janeway, Jr. 1993. Do B cells drive the diversification of immune responses? Immunol. Today 14:151.
43. Jemmerson, R., and Y. Paterson. 1986. Mapping epitopes on a protein antigen by the proteolysis of antigen-antibody complexes. Science 232:1001.
44. Lehmann, P. V., E. E. Sercarz, T. Forsthuber, C. M. Dayan, and G. Gammon. 1993. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol. Today 14:203.
45. Kaufman, D. L., M. Clare-Salzler, J. Tian, T. Forsthuber, G. S. P. Ting, P. Robinson, M. A. Atkinson, E. E. Sercarz, A. J. Tobin, and P. V. Lehmann. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69.
46. Signore, A., P. Pozzilli, E. A. M. Gale, D. Andreani, and P. C. L. Beverley. 1989. The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice. Diabetologia 32:282.
47. 123I-labelled interleukin 2. Eur. J. Endocrinol. 131:431.
48. + T cells that exhibit a transendothelial migratory capacity. J. Immunol. 154:3062.
49. Faveeuw, C., M.-C. Gagnerault, and F. Lepault. 1994. Expression of homing and adhesion molecules in infiltrated islets of Langerhans and salivary glands of nonobese diabetic mice. J. Immunol. 152:5969.
50. Bar, R. S., P. Gorden, J. Roth, C. R. Kahn, and P. De Meyts. 1976. Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients: effects of starvation, refeeding, and dieting. J. Clin. Invest. 58: 1123.
51. Atkinson, M. A., N. K. Maclaren, and R. Luchetta. 1990. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 39:933.
52. Muir, A., A. Peck, M. Clare-Salzler, Y.-H. Song, J. Cornelius, R. Luchetta, J. Krischer, and N. Maclaren. 1995. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intra-islet interferon-γ transcription. J. Clin. Invest. 95:628.
53. Thivolet, C. H., E. Goillot, P. Bedossa, A. Durand, M. Bonnard, and J. Orgiazzi. 1991. Insulin prevents adoptive cell transfer of diabetes in the autoimmune nonobese diabetic mouse. Diabetologia 34:314.
54. Gavin, J. R., III, J. Roth, D. M. Neville, Jr., P. De Meyts, and D. N. Buell. 1974. Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture. Proc. Natl. Acad. Sci. USA 71:84.